Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ELDN has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
ELDN stock price ended at $2.78 on Wednesday, after losing-1.07%
The Eledon Pharmaceuticals Inc stock price decreased by -1.07% on the last trading day (18 Jun 2025), dropping from 2.85 to 2.78. Throughout the last trading session, the stock experienced a fluctuation of 4.88% , ranging from a day low of $2.765 to a day high of 2.9. The price has declined in 5 of the last 10 days, resulting in a total change of -8.25% during this period. On the last day, trading volume increase by -14.61K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 199.42K shares were traded, amounting to approximately 560.71K.
ELDN Technical Signals
ELDN(Eledon Pharmaceuticals Inc Corp) has 5 buy signals and 4 sell signals now. The current trend is consolidation starting from 2025-06-12. The total price change during this trend is -7.33%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of ELDN over the last 5 trading days is 553.27K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
ELDN Moving Average Analysis
Eledon Pharmaceuticals Inc's overall moving average trend leans more bearish as of Friday, June 20, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $3.2114700000000003, and $3.37. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.69853, and $2.54. A break-down below any of these levels will issue sell signals.
ELDN Short Selling Analysis
The short sale ratio of Eledon Pharmaceuticals Inc(ELDN) as of 17 Jun 2025 is 26.98%, rising from last trading day. With increasing price from 2.80 to 2.81. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
4
Buy
5
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
6.641
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-177.441
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
1.367
Bullish
Williams %R (14 days)
WILLR_14 < -80
-96.04
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
22.085
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.144
Bearish
Momentum (10 days)
MOM_10 < 0
-0.25
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.0677
Bearish
Closing price
close < fibonacci_S1
2.78
Bearish
ELDN Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Eledon Pharmaceuticals Inc(ELDN), our algorithm predicts ELDN's 1-month price at $3.09, with an 2.97%upwardshift. Using a similarity score up to 91.06%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Eledon Pharmaceuticals Inc (ELDN.O) stock, as of Sunday, June 1, 2025 , forecasts a 2.97% change over the next month, based on its high correlation with G.N stock patterns. The similarity between their price movements over the analyzed periods is 91.06%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ELDN
No Data
G
Up: 2.97%Similarity: 91.06%
Name
Similarity
Up/Down
G.N
91.06%
+2.97%
ELDN Seasonality Analysis
Based on ELDN's historical stock price data across all years, the probability of a positive return in June is18.18%, suggesting it maynotbe an ideal month to invest in ELDN. In contrast,Novemberoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Eledon Pharmaceuticals Inc (ELDN.O) stock in November has the highest probability of a positive return (60.00%), while December has the lowest probability (10.00%).
Performance Seasonality
The chart shows Eledon Pharmaceuticals Inc. (ELDN)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Eledon Pharmaceuticals Inc (ELDN.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ELDN has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Eledon Pharmaceuticals Inc (ELDN.O) stock in a year?
The radar chart shows that buying Eledon Pharmaceuticals Inc (ELDN.O) stock in November has the highest probability of a positive return (60.00%), while December has the lowest probability (10.00%).
How has Eledon Pharmaceuticals Inc. (ELDN)'s stock price performed over the past three years?
ELDN's stock price fell by -20.70% in 2023,increased by 119.15% in 2024, and went down by 35.2% in 2025.
Bearish technical signals of ELDN include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1.
Is ELDN a buy based on overall technical signals summary?
ELDN has 5 buy signals and 4 sell signals now. Overall the technical rating for ELDN is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ELDN.
What is the trend of Eledon Pharmaceuticals Inc (ELDN)'s moving average?
Eledon Pharmaceuticals Inc's overall moving average trend leans more bearish as of June 20 2025, with 4 negative signals and 0 positive signal.
What is price prediction for ELDN stock next month?
The price prediction chart for Eledon Pharmaceuticals Inc (ELDN.O) stock, as of June 01 2025, forecasts a 2.97% change over the next month, based on its high correlation with G stock patterns. The similarity between their price movements over the analyzed periods is 91.06%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ELDN Stock?
The price prediction for ELDN stock in 2025 is expected to range between $3.20 and $2.80. This forecast is based on current technical indicators showing neutral RSI levels, a slightly bearish MACD, and the stock's position near key Fibonacci and Bollinger Band levels.
What is price prediction 2030 for ELDN Stock?
ELDN stock is predicted to reach **$15.00 by 2030**, driven by positive clinical trial results for tegoprubart and strong analyst sentiment with a $11.00 target. The stock's successful application in xenotransplantation and upcoming trial data position it for significant growth.